Clinical trial · Interventional
Comparing the QoR of PECS Block and GA in Breast-conserving Surgery With Sentinel Lymph Node Biopsy
Comparing the Quality of Recovery(QoR) of Pectoral Nerves(PECS) Block and General Anesthesia(GA) in Breast-conserving Surgery(BCS) With Sentinel Lymph Node Biopsy(SLNB):A Randomized Controlled Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this randomized controlled trial (RCT) is to assess the Quality of Recovery (QoR) in Breast-conserving Surgery (BCS) with Sentinel Lymph Node Biopsy (SLNB) using Pectoral Nerves (PECS) Block and General Anesthesia (GA). The primary objectives are as follows: First, to determine if the PECS group exhibits better QoR; Second, to investigate if the PECS group experiences less postoperative pain and complications; Third, to examine if the PECS group demonstrates more stable hemodynamics.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Breast-Conserving Surgery | — | UNRESOLVED | — |
| Pectoral Nerves Block | — | UNRESOLVED | — |
| Sentinel Lymph Node Biopsy | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| General anesthesia with laryngeal mask | Combination Product | — | UNRESOLVED |
| PECS II combined with intercostal nerve blockade; | Combination Product | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- T Group
- description
- The T Group received PECS II(PMID: 22939099) combined with intercostal nerve block
- interventionNames
- Combination Product: PECS II combined with intercostal nerve blockade;
- type
- ACTIVE_COMPARATOR
- label
- C Group
- description
- C Group underwent laryngeal mask insertion after general anesthesia induction.
- interventionNames
- Combination Product: General anesthesia with laryngeal mask
Primary outcomes (1)
- measure
- Postoperative QoR-15 at 6 hours
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Patients scheduled for breast-conserving surgery with sentinel lymph node biopsy. * Age between 18 and 70 years. * Body Mass Index (BMI) \< 30 kg/m2. * American Society of Anesthesiologists (ASA) classification grade I-III. Exclusion Criteria: * Contraindications to regional anesthesia: site infection at the puncture site, allergy to local anesthetics, coagulation disorders, or bleeding risks. * Impaired liver or kidney function. * Pregnancy, lactation, possibility of pregnancy, or planned pregnancy. * Preoperative use of analgesic drugs, history of chronic pain, or history of opioid abuse. * Mental illness. * Patients who refuse to participate. * Patients deemed unsuitable for the clinical trial by the researchers.
References
Publications (0)
Data not yet available